Peter Zhao, MD is an Instructor in Medicine in the Division of Hospital Medicine. He is experienced in taking care of bone marrow transplant and oncology patients in the acute inpatient setting. His primary area of interest is hematologic malignancies, including acute leukemia and lymphoma. He has assisted in clinical teaching for medical students as well as residents. He serves on the hospitalist BMT/Oncology Committee to help identify challenges in service workflow.
Education
- BS, Chemistry: Emory University (2011)
- Medical Degree: Washington University School of Medicine in St. Louis, St. Louis, MO (2015)
- Residency, Internal Medicine: Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, MO (2018)
Board Certifications
- American Board of Internal Medicine
Clinical Interests
Hospital medicine, inpatient care
Publications
William H. Eschenbacher , Moshi Song , Yun Chen, Poonam Bhandari, Peter Zhao, Casey C. Jowdy, John T. Engelhard, Gerald W. Dorn II. “Two rare human mitofusin 2 mutations alter mitochondrial dynamics and induce retinal and cardiac pathology in Drosophila.” PloS one 7.9 (2012): e44296.
Christopher A. Koczor, Richard C. White, Peter Zhao, Linjue Zhu, Earl Fields, William Lewis. “p53 and mitochondrial DNA: their role in mitochondrial homeostasis and toxicity of antiretrovirals.” The American journal of pathology 180.6 (2012): 2276-2283.
Poster Presentations
Internal Medicine Scholars Symposium: “Brentuximab Vedotin as Primary Prevention of Acute GVHD,” May 17, 2017.
Siteman Hematopoiesis Development and Malignancy Program Retreat: Brentuximab Vedotin as Primary Prevention of Acute GVHD,” June 15, 2016.